Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BKNG | BOOKING HOLDINGS INC | $136.16B | $27.69B | $9.80B | $6.15B | $7.68 | 14.95% | 37.42% | 17.79% | 62.16% | 2026-07-29 | ||
| FBLG | FIBROBIOLOGICS INC | $4.22M | $0.00 | -$17.56M | -$18.68M | -$6.93 | N/A | N/A | N/A | N/A | |||
| VNRX | VOLITIONRX LTD | $11.66M | $2.47M | -$22.87M | -$24.60M | -$4.17 | 88.49% | 129.88% | N/A | N/A | |||
| IMMP | IMMUTEP LTD | $52.46M | $7.65M | N/A | -$59.52M | -$0.41 | 5.96% | 3.01% | N/A | N/A | |||
| NRSN | NEUROSENSE THERAPEUTICS LTD | $22.76M | $0.00 | -$11.11M | -$11.13M | -$0.44 | N/A | N/A | N/A | N/A | 2026-06-22 | ||
| HELP | CYBIN INC | $214.05M | $0.00 | -$96.64M | -$96.75M | -$3.64 | N/A | N/A | N/A | N/A | |||
| PSTV | PLUS THERAPEUTICS INC | $31.46M | $5.18M | -$11.69M | -$11.93M | -$1.55 | -0.46% | 94.74% | N/A | N/A | |||
| IVVD | INVIVYD INC | $262.79M | $55.87M | -$75.72M | -$77.60M | -$0.31 | 52.27% | N/A | N/A | N/A | |||
| ATOS | ATOSSA THERAPEUTICS INC | $19.12M | $0.00 | -$37.63M | -$37.64M | -$4.55 | N/A | N/A | N/A | N/A | |||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $94.15M | $3.17M | -$24.69M | -$29.44M | -$0.29 | 164.08% | 22.82% | N/A | N/A | |||
| CNTX | CONTEXT THERAPEUTICS INC | $59.72M | $0.00 | -$40.10M | -$40.23M | -$0.42 | N/A | N/A | N/A | N/A | |||
| RNXT | RENOVORX INC | $39.69M | $1.49M | -$12.18M | -$12.27M | -$0.33 | 520.42% | N/A | N/A | N/A | |||
| NRXP | NRX PHARMACEUTICALS INC | $143.83M | $2.29M | -$23.33M | -$24.54M | -$1.09 | N/A | N/A | N/A | N/A | |||
| TNYA | TENAYA THERAPEUTICS INC | $147.56M | $225.00k | -$72.94M | -$83.01M | -$0.46 | N/A | N/A | N/A | N/A | 2026-08-12 | ||
| SXTP | 60 DEGREES PHARMACEUTICALS INC | $3.88M | $397.44k | -$7.48M | -$8.06M | -$8.95 | 56.03% | N/A | N/A | N/A | |||
| OSTX | OS THERAPIES INC | $78.83M | $0.00 | -$34.71M | -$35.27M | -$1.08 | N/A | N/A | N/A | N/A | |||
| CTXR | CITIUS PHARMACEUTICALS INC | $14.88M | $5.61M | -$45.06M | -$46.20M | -$2.24 | N/A | N/A | N/A | N/A | 2026-08-14 | ||
| BTAI | BIOXCEL THERAPEUTICS INC | $37.05M | $680.00k | -$57.86M | -$75.33M | -$4.52 | -63.28% | N/A | N/A | N/A | |||
| KSCP | KNIGHTSCOPE INC | $34.16M | $14.43M | -$34.56M | -$37.24M | -$3.54 | 25.86% | N/A | N/A | N/A | |||
| AVXL | ANAVEX LIFE SCIENCES CORP | $233.53M | $0.00 | -$39.93M | -$39.95M | -$0.46 | N/A | N/A | N/A | N/A | |||
| CMPX | COMPASS THERAPEUTICS INC | $354.77M | $0.00 | -$66.70M | -$68.17M | -$0.40 | -100.00% | N/A | N/A | N/A | |||
| RCT | REDCLOUD HOLDINGS PLC | $38.59M | $48.54M | -$41.33M | -$46.24M | -$1.03 | 4.39% | N/A | N/A | N/A | |||
| OCGN | OCUGEN INC | $399.46M | $4.47M | -$63.28M | -$71.67M | -$0.24 | -1.26% | 153.09% | N/A | N/A | 2026-07-30 | ||
| BMEA | BIOMEA FUSION INC | $83.87M | $0.00 | -$42.88M | -$44.95M | -$0.68 | N/A | N/A | N/A | N/A | |||
| CRDL | CARDIOL THERAPEUTICS INC | $118.58M | $0.00 | -$26.65M | -$26.73M | -$0.29 | N/A | N/A | N/A | N/A | |||
| ELTX | ELICIO THERAPEUTICS INC | $52.68M | $0.00 | -$37.68M | -$40.19M | -$2.40 | N/A | -100.00% | N/A | N/A | |||
| VERU | VERU INC | $50.24M | $0.00 | -$13.84M | -$13.95M | -$0.78 | N/A | -100.00% | N/A | N/A | 2026-08-12 | ||
| GUTS | FRACTYL HEALTH INC | $123.11M | $0.00 | -$105.25M | -$108.00M | -$1.29 | -100.00% | N/A | N/A | N/A | |||
| LUNG | PULMONX CORP | $52.80M | $88.55M | -$46.72M | -$53.21M | -$1.30 | 1.23% | 21.56% | N/A | N/A | 2026-07-29 | ||
| ALGS | ALIGOS THERAPEUTICS INC | $30.88M | $4.71M | -$90.44M | -$90.32M | -$8.79 | 43.88% | 38.90% | N/A | N/A | 2026-08-06 | ||
| CRBU | CARIBOU BIOSCIENCES INC | $167.62M | $8.81M | -$128.97M | -$133.22M | -$1.42 | 16.40% | -6.38% | N/A | N/A | |||
| INTZ | INTRUSION INC | $15.52M | $6.21M | -$8.83M | -$10.52M | -$0.52 | -3.23% | -1.44% | N/A | N/A | 2026-08-11 | ||
| NAKA | NAKAMOTO INC | $77.61M | $3.92M | -$277.41M | -$289.97M | -$6.80 | 58.64% | N/A | N/A | N/A | |||
| TARA | PROTARA THERAPEUTICS INC | $214.14M | $0.00 | -$62.94M | -$63.31M | -$1.35 | N/A | N/A | N/A | N/A | 2026-08-11 | ||
| AUTL | AUTOLUS THERAPEUTICS PLC | $396.57M | $92.62M | -$246.39M | -$288.97M | -$1.09 | 927.90% | 123.90% | N/A | N/A | 2026-08-14 | ||
| HOVR | NEW HORIZON AIRCRAFT LTD | $98.67M | $0.00 | -$23.47M | -$23.96M | -$0.69 | N/A | N/A | N/A | N/A | |||
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $96.27M | $0.00 | -$42.95M | -$43.21M | -$0.77 | -100.00% | N/A | N/A | N/A | |||
| MDXH | MDXHEALTH SA | $2.76M | $110.97M | $1.22M | -$33.18M | -$6.40 | 17.42% | N/A | N/A | N/A | |||
| MNOV | MEDICINOVA INC | $64.48M | $596.64k | -$11.53M | -$11.72M | -$0.23 | N/A | -31.65% | N/A | N/A | 2026-08-13 | ||
| ACET | ADICET BIO INC | $72.54M | $0.00 | -$99.45M | -$108.83M | -$13.87 | N/A | -100.00% | N/A | N/A | |||
| CAN | CANAAN INC | $239.45M | $509.65M | N/A | -$212.58M | -$0.34 | 60.77% | 35.06% | N/A | N/A | 2026-08-13 | ||
| CING | CINGULATE INC | $62.93M | $0.00 | -$27.22M | -$27.71M | -$4.23 | N/A | N/A | N/A | N/A | |||
| ENGN | ENGENE THERAPEUTICS INC | $117.23M | $0.00 | -$122.69M | -$126.85M | -$2.17 | N/A | N/A | N/A | N/A | |||
| NSRX | NASUS PHARMA LTD | $27.68M | $0.00 | -$5.92M | -$5.86M | -$0.72 | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.